Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial

Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    This update reflects a change to the site’s interface/version label (revision v3.5.3 instead of v3.5.2) without altering the underlying clinical trial record history content.
    Difference
    0.0%
    Check dated 2026-04-23T21:56:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added a new revision entry v3.5.2 and removed the v3.5.0 entry from the history.
    Difference
    0.0%
    Check dated 2026-04-16T12:32:48.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.5.0 replaces Revision: v3.4.3 in the record history.
    Difference
    0.0%
    Check dated 2026-03-18T22:48:28.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T20:02:03.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior funding-status notice and the Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T10:55:32.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a site-wide notice regarding a lapse in government funding and updated system revision to v3.4.1 (from v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T10:20:32.000Z thumbnail image

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.